First Time Loading...

Taisho Pharmaceutical Holdings Co Ltd
TSE:4581

Watchlist Manager
Taisho Pharmaceutical Holdings Co Ltd Logo
Taisho Pharmaceutical Holdings Co Ltd
TSE:4581
Watchlist
Price: 999 999.9999 JPY Market Closed
Updated: Apr 29, 2024
Section:
 

Relative Value

The Relative Value of one Taisho Pharmaceutical Holdings Co Ltd stock under the Base Case scenario is 4 500.4817 JPY. Compared to the current market price of 999 999.9999 JPY, Taisho Pharmaceutical Holdings Co Ltd is Overvalued by 100%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
4 500.4817 JPY
Overvaluation 100%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

255.8
P/S
P/S
Price to Sales
255.8
vs History
0
vs Industry
2
Median 3Y
1.6
Median 5Y
1.7
Industry
2.4
Forward
252.2
More Details
9 733.7
P/E
P/E
Price to Earnings
9 733.7
vs History
0
vs Industry
100
Median 3Y
32.5
Median 5Y
30.7
Industry
22.9
Forward
6 848.3
More Details
4 265.1
P/OCF
P/OCF
Price to OCF
4 265.1
vs History
0
vs Industry
0
Median 3Y
14.2
Median 5Y
14.4
Industry
17.1
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
11
Median 3Y
18.6
Median 5Y
20.4
Industry
23.2
More Details
98.5
P/B
P/B
Price to Book Value
98.5
vs History
0
vs Industry
0
Median 3Y
0.6
Median 5Y
0.7
Industry
2.1
More Details
255
EV/S
EV/S
Enterprise Value to Sales
255
vs History
0
vs Industry
1
Median 3Y
0.7
Median 5Y
0.9
Industry
2.6
Forward
251.4
More Details
446.1
EV/GP
EV/GP
Enterprise Value to Gross Profit
446.1
vs History
0
vs Industry
1
Median 3Y
1.2
Median 5Y
1.4
Industry
5.1
More Details
1 771.8
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
1 771.8
vs History
0
vs Industry
0
Median 3Y
5.3
Median 5Y
6.2
Industry
13.6
Forward
1 618.6
More Details
4 320.3
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
4 320.3
vs History
0
vs Industry
0
Median 3Y
12.3
Median 5Y
12.3
Industry
17
Forward
3.5
More Details
4 251.3
EV/OCF
EV/OCF
Enterprise Value to OCF
4 251.3
vs History
0
vs Industry
0
Median 3Y
5.6
Median 5Y
6.5
Industry
15.8
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
14
Median 3Y
8.1
Median 5Y
9.9
Industry
17.6
More Details
113.1
EV/IC
EV/IC
Enterprise Value to IC
113.1
vs History
0
vs Industry
1
Median 3Y
0.3
Median 5Y
0.4
Industry
1.9
More Details

Multiples Across Competitors

Competitors Multiples
Taisho Pharmaceutical Holdings Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
JP
Taisho Pharmaceutical Holdings Co Ltd
TSE:4581
82T JPY 255.8 9 733.7 1 771.8 4 320.3
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
696.4B USD 20.4 132.9 60.1 68.9
DK
Novo Nordisk A/S
CSE:NOVO B
4T DKK 17 47.2 34.6 37.7
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
351.8B USD 4.3 8.7 11.6 15.3
US
Merck & Co Inc
NYSE:MRK
332.2B USD 5.5 910 45.2 88.2
UK
AstraZeneca PLC
LSE:AZN
185.8B GBP 5.1 39 140.5 225.4
CH
Novartis AG
SIX:NOVN
182.9B CHF 4.3 13.5 9.9 16.3
CH
Roche Holding AG
SIX:ROG
176.2B CHF 3 15.3 8.5 10
US
Pfizer Inc
NYSE:PFE
143.4B USD 2.5 67.7 10.3 15.3

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 132,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.